Contensis CMS on the UK Government CloudStore
Posted on Monday 3rd December 2012
Here at Genetics Limited, we are delighted to announce that we have been awarded a position on the Government Procurement Service’s G-Cloud 2 Framework Agreement. As of today, twenty eight of our Software-as-a-Service (SAAS) offerings can be seen on the CloudStore. The product range encompasses the Contensis Enterprise Content Management System, together with modules and extensions, covering a wide range of organisational scales and requirements.
The transition to offering Cloud-based solutions is a straightforward one for us, as we have been providing remotely hosted solutions to public sector clients for a decade. Contensis is a natural fit for this, since it offers the only truly decoupled publishing model of any UK CMS product. This gives unprecedented flexibility and resilience to the published websites, and helps CloudStore clients achieve the agility and cost effectiveness that the GPS are looking for out of the framework.
We have already begun discussions with a number of potential clients who are interested in the CloudStore approach to procuring their next CMS. We are fully behind the initiative, as it offers substantial time and cost savings on both sides.
You can see the full Contensis SAAS range at the CloudStore, and feel free to talk to us about anything you see there.
Notes to editors:
For further information contact Mark Owen: m.owen@contensis.co.uk
A demonstration of Contensis can be easily arranged. Please contact Mark to arrange a date and time to suit you.
For all logos and imagery please see our Press Centre, or if you need something in particular just let us know!
Company Background
Established in 2001, Contensis has been in the web content management field for over 10 years.
The company is based just outside Ludlow, in south Shropshire and employs around 25 staff.
Contensis is the CMS of choice for many leading organisations, powering multiple sites for organisations such as Pearson Education, Henderson Global Investors, Macmillan Cancer Support, the Royal Institute of British Architects, Goodwood Estate, plus major universities, including Birmingham University, Nottingham University, The LSE and the European University Institute in Florence, Italy.
Contensis is a product wholly owned and developed by Genetics Ltd, an ISO 9001:2008 quality-accredited company.